Adult immunization rates are low and continue to fail to meet national targets. The coronavirus disease 2019 pandemic halted routine health care services for many, including vaccinations. In collaboration with the American Medical Group Association and GlaxoSmithKline, Discern Health presents findings from a real-world evaluation of three US health care organizations in a new Population Health Management study.
This study explored whether the National Committee for Quality Assurance’s Adult Immunization Status (AIS) measure, which had previously only been evaluated for reporting by health plans, could be leveraged by health care organizations as a tactic to improve immunization rates. As a result of this study, the authors concluded that the AIS measure is feasible for use in medical groups and could potentially help drive quality improvements in immunization rates. However, there are considerations for implementation particularly if providers are being held accountable for measure performance.